The O-arm O2 Imaging System is a mobile x-ray system designed for 2D fluoroscopic and 3D imaging ...
FDA Device Recall #Z-2449-2023 — Class II — July 25, 2023
Recall Summary
| Recall Number | Z-2449-2023 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 25, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Medtronic Navigation, Inc.-Littleton |
| Location | Littleton, MA |
| Product Type | Devices |
| Quantity | 28 units |
Product Description
The O-arm O2 Imaging System is a mobile x-ray system designed for 2D fluoroscopic and 3D imaging for adult and pediatric patients weighing 60 lbs. or greater and having an abdominal thickness greater than 16 cm and is intended to be used where a physician benefits from 2D and 3D information of anatomic structures and objects with high x-ray attenuation such as bony anatomy and metallic objects.
Reason for Recall
Ground cable installed incorrectly.
Distribution Pattern
Worldwide - US Nationwide distribution in the states of CA, CO, FL, IA, IL, IN, KY, MI, MO, NC, NV, OH, TN, UT, VA, & WA. The countries of Canada, Ireland, Poland, Russian Federation, Switzerland, & Viet Nam.
Lot / Code Information
Model No. BI70002000; UDI-DI: 00763000074128, 00763000081041, 00763000355555, 00763000496784, 00763000542801, 00763000616434, 00763000616526, 00763000616564; Serial No. C2786, C2841, C2781, C2624, C2659, C2660, C2665, C2672, C2708, C2723, C2735, C2760, C2774, C2775, C2779, C2798, C2814, C2823, C2873, C2918, C2968, C3290, C3363, C3188, C3322, C3387, C3404, and C3418.
Other Recalls from Medtronic Navigation, Inc.-Littleton
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2026-2024 | Class II | O-arm O2 Imaging System-Mobile x-ray system des... | Apr 26, 2024 |
| Z-0767-2020 | Class II | O-arm" O2 Imaging System, Product Number/CFN: B... | Nov 15, 2019 |
| Z-1932-2019 | Class II | Medtronic 0-arm TM 1000 Imaging Systems: Bl-700... | May 1, 2019 |
| Z-0404-2019 | Class II | Medtronic Navigation 0-arm 02 Imaging System in... | Sep 17, 2018 |
| Z-0271-2019 | Class II | O-arm 1000 2nd Edition Imaging System, OARM ASS... | Aug 30, 2018 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.